Recursion Pharmaceuticals (RXRX) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.45
-0.41
-0.37
-0.33

Details

Expected EPS
-0.332835
Actual EPS
-0.34
Surprise EPS
-0.01
Surprise Percent
+2.15%

Description

Recursion Pharmaceuticals (RXRX) has reported earnings of -0.34 per share for Q4 2024.

0 Comments

Share your thoughts